🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →
S&P 500: 670.79 +0.3% NASDAQ 100: 603.31 +0.5% Dow Jones: 470.90 +0.1%

Joel Greenblatt’s CAH Holdings & Trades

First Buy
Q2 2013
Duration Held
45 Quarters
Largest Add
Q2 2018
+574,383 Shares
Current Position
166,212 Shares
$34.16 M Value

Joel Greenblatt's CAH Position Overview

Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 166,212 shares of Cardinal Health, Inc. (CAH) worth $34.16 M, representing 0.12% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 45 quarters.

Based on 13F filings since 2013, Joel Greenblatt has maintained a long-term strategic position in CAH, representing a significant commitment to this investment thesis. Largest addition occurred in Q2 2018, adding 574,383 shares. Largest reduction occurred in Q4 2016, reducing 517,693 shares.

Analysis based on 13F filings available since 2013 Q2

Joel Greenblatt's Cardinal Health (CAH) Holding Value Over Time

Track share changes against reported price movement

Quarterly Cardinal Health (CAH) Trades by Joel Greenblatt

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q4 2025 +33,203 Add 24.96% 166,212 $205.50
Q3 2025 +21,077 Add 18.83% 133,009 $156.96
Q2 2025 +73,237 Add 189.27% 111,932 $168.00
Q1 2025 +12,061 Add 45.28% 38,695 $137.77
Q4 2024 -2,981 Reduce 10.07% 26,634 $118.27
Q3 2024 -38,842 Reduce 56.74% 29,615 $110.52
Q2 2024 -4,872 Reduce 6.64% 68,457 $98.32
Q1 2024 +8,917 Add 13.84% 73,329 $111.90
Q4 2023 +9,679 Add 17.68% 64,412 $100.80
Q3 2023 -50,305 Reduce 47.89% 54,733 $86.82
Q2 2023 +36,522 Add 53.30% 105,038 $94.57
Q1 2023 -41,622 Reduce 37.79% 68,516 $75.50
Q4 2022 -34,861 Reduce 24.04% 110,138 $76.87
Q3 2022 +138,227 Add 2041.15% 144,999 $66.68
Q2 2022 +6,772 New Buy 6,772 $52.27
Q1 2021 -44,718 Sold Out 0 $0.00
Q4 2020 -41,098 Reduce 47.89% 44,718 $53.56
Q3 2020 -58,249 Reduce 40.43% 85,816 $46.95
Q2 2020 +144,065 New Buy 144,065 $52.19
Q1 2020 -107,580 Sold Out 0 $0.00
Q4 2019 -233,297 Reduce 68.44% 107,580 $50.58
Q3 2019 +45,273 Add 15.32% 340,877 $47.19
Q2 2019 -111,609 Reduce 27.41% 295,604 $47.10
Q1 2019 -30,358 Reduce 6.94% 407,213 $48.15
Q4 2018 +1,246 Add 0.29% 437,571 $44.60
Q3 2018 -138,058 Reduce 24.04% 436,325 $54.00
Q2 2018 +574,383 New Buy 574,383 $48.83
Q1 2018 -277,754 Sold Out 0 $0.00
Q4 2017 +277,754 New Buy 277,754 $61.27
Q1 2017 -74,164 Sold Out 0 $0.00
Q4 2016 -517,693 Reduce 87.47% 74,164 $71.98
Q3 2016 -176,515 Reduce 22.97% 591,857 $77.70
Q2 2016 +529,878 Add 222.18% 768,372 $78.01
Q1 2016 +232,649 Add 3980.31% 238,494 $81.95
Q4 2015 -254,210 Reduce 97.75% 5,845 $89.31
Q3 2015 +58,852 Add 29.25% 260,055 $76.82
Q2 2015 -34,314 Reduce 14.57% 201,203 $83.65
Q1 2015 -7,870 Reduce 3.23% 235,517 $90.27
Q4 2014 -110,232 Reduce 31.17% 243,387 $80.73
Q3 2014 -326,443 Reduce 48.00% 353,619 $74.92
Q2 2014 +300,754 Add 79.29% 680,062 $68.56
Q1 2014 +121,983 Add 47.40% 379,308 $69.98
Q4 2013 +113,419 Add 78.81% 257,325 $66.81
Q3 2013 +127,419 Add 772.85% 143,906 $52.15
Q2 2013 +16,487 Add 0.00% 16,487 $47.19

Joel Greenblatt's Cardinal Health Investment FAQs

Joel Greenblatt first purchased Cardinal Health, Inc. (CAH) in Q2 2013, acquiring 16,487 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Joel Greenblatt has held Cardinal Health, Inc. (CAH) for 45 quarters since Q2 2013.

Joel Greenblatt's largest addition to Cardinal Health, Inc. (CAH) was in Q2 2018, adding 574,383 shares worth $28.05 M.

According to the latest 13F filing for Q4 2025, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 166,212 shares of Cardinal Health, Inc. (CAH), valued at approximately $34.16 M.

As of the Q4 2025 filing, Cardinal Health, Inc. (CAH) represents approximately 0.12% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.

Joel Greenblatt's peak holding in Cardinal Health, Inc. (CAH) was 768,372 shares, as reported at the end of Q2 2016.